patent/GE-P20074251-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GE-P20074251-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
filingDate	2006-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6b3f8fd567c33b4d0e14318edab03bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1b82bbbc695e7b26deee3899b14ac2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a25da9e375d6fddfed22187de30dedb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7444f22afd5558b3c8d72b98caca93bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae00df27a9c95d9aff233aace8a55be8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb975261ba5da22831b3c8ae8213cf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_533e25c32d2d93abf8cdc80bd7df2838
publicationDate	2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	GE-P20074251-B
titleOfInvention	N-oxycarbonyl substituted 5'- deoxy-5-fluorocytidines
abstract	Compounds of the formula I hydrates or solvates thereof, the radicals of which are provided in the description, method for their production, pharmaceutical composition on its base and use thereof for production of anti-tumour agent. Tables: 4
priorityDate	1992-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10037499 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414380518

Total number of triples: 31.